Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Hua Dong Medicine’s HDM2020 Gains NMPA Approval for Clinical Trials
June 27, 2025
Company
Drug
Cutia Therapeutics’ Phase III Results for Lidocaine-Tetracaine Cream to be Presented at CSD Meeting
June 27, 2025
Company
Deals
Novartis Completes Acquisition of Regulus Therapeutics for ADPKD Treatment
June 27, 2025
Company
Drug
Sino Biopharmaceutical’s LM-108 Gains CDE BTD for Gastric Adenocarcinoma
June 27, 2025
Company
Deals
Mabwell Bioscience Grants Qilu Pharma Exclusive Rights to Mailisheng in Greater China
June 27, 2025
Company
Drug
Fosun Pharma’s Serplulimab Approved for ES-SCLC in the UK and India
June 26, 2025
Company
Drug
Sanofi’s Riliprubart Granted Orphan Drug Status for Antibody-Mediated Rejection Treatment
June 26, 2025
Company
Drug
Bio-Thera Solutions Initiates Phase III Trial of BAT8006 for Platinum-Resistant Ovarian Cancer
June 26, 2025
Company
AstraZeneca Restructures to Form Gastrointestinal Oncology Business Unit
June 26, 2025
Company
Drug
EMA Panel Recommends Brukinsa Tablet Formulation for Approval
June 26, 2025
Company
Drug
Sinocelltech Wins NMPA Clearance for TriAb SCTB39G in Solid Tumors
June 26, 2025
Company
Drug
CARsgen’s Satri-cel NDA Accepted by China’s NMPA for Gastric Adenocarcinoma
June 26, 2025
1
2
…
320
321
322
323
324
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
